Status:

COMPLETED

Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4)

Lead Sponsor:

University Health Network, Toronto

Collaborating Sponsors:

Princess Margaret Hospital, Canada

Conditions:

Hepatocellular Carcinoma

Hepatic Metastasis

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Palliative radiotherapy is radiation treatment given to help reduce pain or discomfort, or other symptoms related to cancer. This is used commonly for cancer that has spread to the bones and brain, an...

Detailed Description

The liver is one of the most common sites with tumour involvement, including both primary and metastatic disease. Gastrointestinal tumours, breast, lung and melanoma are the most common primary sites ...

Eligibility Criteria

Inclusion

  • Patients with hepatocellular carcinoma or hepatic metastases from a solid malignancy, unsuitable for radical therapy (including resection, transplant, conformal high dose radiotherapy), confirmed by biopsy or imaging
  • Symptoms of hepatic pain, discomfort, nausea, or fatigue requiring palliation
  • KPS\>60
  • Expected survival of greater than 3 months
  • Platelet count \> 25 bil/L, Hemoglobin \> 70 g/L, INR\<3, Bilirubin\<100 umol/L, AST \< 350 U/L or ALT\< 400 U/L
  • Have signed an informed consent form approved by the Research Ethics Board (REB) at Princess Margaret Hospital

Exclusion

  • Chemotherapy or novel drug within the past 2 weeks
  • TACE(transarterial chemoembolization)within the past 1 month
  • Plan for active treatment of the hepatocellular carcinoma or hepatic metastases, including TACE or RFA or ETOH injection

Key Trial Info

Start Date :

February 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 26 2018

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00923897

Start Date

February 1 2007

End Date

September 26 2018

Last Update

June 18 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Health Network, Princess Margaret Hospital

Toronto, Ontario, Canada, M5G 2M9

Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4) | DecenTrialz